Peregrine Investment Management Inc. Has $11.35 Million Position in Astera Labs, Inc. $ALAB

Peregrine Investment Management Inc. decreased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 29.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 68,220 shares of the company’s stock after selling 28,850 shares during the quarter. Astera Labs comprises approximately 7.0% of Peregrine Investment Management Inc.’s investment portfolio, making the stock its 2nd largest position. Peregrine Investment Management Inc.’s holdings in Astera Labs were worth $11,349,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Hilltop National Bank increased its holdings in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new position in shares of Astera Labs during the fourth quarter valued at $33,000. National Bank of Canada FI increased its holdings in shares of Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares in the last quarter. Finally, Wexford Capital LP bought a new position in shares of Astera Labs during the third quarter valued at $39,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ALAB. Weiss Ratings upgraded Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Stifel Nicolaus raised their price target on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Barclays raised their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Finally, Citigroup raised their price target on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $229.65.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $204.42 on Wednesday. The stock has a market capitalization of $35.04 billion, a price-to-earnings ratio of 138.12, a PEG ratio of 3.42 and a beta of 3.35. The stock’s 50-day simple moving average is $148.57 and its two-hundred day simple moving average is $155.00. Astera Labs, Inc. has a 52-week low of $81.14 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs was highlighted as a company that could help solve a major AI infrastructure bottleneck, reinforcing its role in high-speed connectivity for AI data centers. Astera Labs (ALAB) Touted To Solve Big AI Bottleneck
• Positive Sentiment: Zacks said demand remains strong for Astera Labs’ Scorpio portfolio, which already contributes more than one-third of revenue and could become the company’s largest product line by 2026. Astera Labs Rides on Strong Scorpio Portfolio: What Lies Ahead?
• Positive Sentiment: Needham raised its price target to $260 from $220 and kept a Buy rating, citing another strong beat-and-raise quarter, which supports bullish sentiment around ALAB. Is Astera Labs. (ALAB) the Best American Semiconductor Stock to Buy According to Analysts?
• Positive Sentiment: The stock was also featured as a potential beneficiary of the AI inference boom, keeping attention on Astera Labs’ growth tied to AI spending. 5 Stocks Positioned to Benefit From the AI Inference Boom (ALAB)
• Neutral Sentiment: Astera Labs announced participation in several upcoming financial conferences, which is a routine investor-relations update and not a major fundamental catalyst. Astera Labs Announces Second Quarter 2026 Financial Conference Participation
• Negative Sentiment: CEO Jitendra Mohan, COO Sanjay Gajendra, and director Stefan A. Dyckerhoff all sold shares in recent pre-arranged 10b5-1 transactions, which can pressure sentiment even though the sales were scheduled in advance. Astera Labs (NASDAQ:ALAB) CEO Jitendra Mohan Sells 139,951 Shares of Stock
• Negative Sentiment: Artisan Mid Cap Fund reduced its holdings in Astera Labs, adding another sign of institutional profit-taking or caution after the stock’s strong run. Here’s Why Artisan Mid Cap Fund Reduced Its Holdings in Astera Labs (ALAB)

Insider Transactions at Astera Labs

In other news, COO Sanjay Gajendra sold 230,639 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $198.22, for a total transaction of $45,717,262.58. Following the completion of the transaction, the chief operating officer directly owned 664,361 shares in the company, valued at approximately $131,689,637.42. This represents a 25.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,497,338 shares of company stock valued at $236,827,957 over the last quarter. 12.50% of the stock is owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.